Clinical Trials Directory

Trials / Completed

CompletedNCT03489538

Homocysteine After Laparoscopic Roux-enY Gastric Bypass

Homocysteine After Laparoscopic Roux-enY Gastric Bypass: a Comprehensive Evalutation in 708 Patients

Status
Completed
Phase
Study type
Observational
Enrollment
708 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Changes in homocysteine values after bariatric surgery remain controversially discussed. This is the first comprehensive summary to depict timeline changes in homocysteine levels following laparoscopic roux-en-Y gastric bypass.

Detailed description

Homocysteine is an independent risk factor for cardiovascular disease. Changes in homocysteine levels following bariatric surgery remain controversially discussed. 708 consecutive patients underwent laparoscopic roux-en-Y gastric bypass over a 6 year period. Throughout their routine follow-up, demographic data as well as homocysteine, folate and vitamin B12 were retrospectively collected at the timepoints: preoperatively, at 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, 84, and 96 months postoperatively. In order to reveal clinical relevance of the results, patients were sent a special questionnaire accompanied by an informed consent form for participation and asked for cardiovascular disease events (myocardial infarction, stroke, deep venous thrombosis) or any other hospital stay after the surgery and cross checked with two region wide databases which account for approx. 80% of all hospital contacts in the region. Additionally, the database was networked with the statewide death registry in order to reveal deceased subjects and data about their demise through the beforementioned databases was collected.

Conditions

Interventions

TypeNameDescription
PROCEDURElaparoscopic long limb roux-en-Y gastric bypassstandard laparoscopic roux-en-Y gastric bypass (biliopancreatic limb 40 to 60 cm, alimentary limb 150 cm)

Timeline

Start date
2013-04-09
Primary completion
2017-09-11
Completion
2017-09-11
First posted
2018-04-05
Last updated
2018-04-05

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT03489538. Inclusion in this directory is not an endorsement.